Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion


Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totaling more than $1 billion. 

The company’s experimental vaccine is currently in early stage human trials and is expected to begin late-stage human trials in September, executives have previously said. The deal gives the U.S. the option to order an additional 200 million doses, according to the announcement. 

“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Dr. Paul Stoffels, chief science officer at Johnson & Johnson, in a statement. 

The U.S. earlier this year awarded J&J $456 million to develop its vaccine. The company said its goal is to supply more than 1 billion doses globally through 2021. 

The doses will be provided to Americans at no cost if they’re used in a Covid-19 vaccination campaign, the U.S. Department of Health and Human services said in a separate press release. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.